Guenter Henze (Günter Henze)

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Larisa Fechina, Alexander M Popov, Grigory A Tsaur, Guenter Henze, Egor Shorikov, Olga Makarova, Olga Khlebnikova, Yulia Zhukova, Oleg Arakaev, Olga Streneva, Tatiana Verzhbitskaya, Tatiana Riger, Alexander Solodovnikov, Elena Lapotentova, Olga V Aleinikova, Natalia Myakova, Elmira Boichenko, Konstantin Kondratchik, Olga Nikonova, Alexander Shapochnik, Marina Goroshkova, Natalia Ponomareva, Galina A Novichkova, Alexander Karachunskiy, Alexander Roumiantsev
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial. Leukemia (2023)
Michela Carlet, Karin Schmelz, Jenny Vergalli, Tobias Herold, Daniela Senft, Vindi Jurinovic, Thomas Hoffmann, Jutta Proba, Nina Weichert, Christian Junghanß, Mareike Roth, Georg Eschenburg, Malwine Jeanette Barz, Guenter Henze, Cornelia Eckert, Angelika Eggert, Johannes Zuber, Patrick Hundsdoerfer, Irmela Jeremias
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL. EMBO molecular medicine (2022)

Guenter Henze.css-eqlu8i{font-size:small;padding-left:4px;} (Günter Henze)